Goldman Sachs: Investors should bet on these parts of the stock market
The New York-based investment bank believes optimism surrounding the approval of a COVID-19 vaccine before Dec. 31 has been countered by the near-term unpredictability of reopening schools, the outcome of coronavirus relief negotiations and the upcoming presidential election.
Comments
Post a Comment